Journal profile · IMMUNOLOGY

Indian Journal of Medical Microbiology

ISSN 0255-0857 · eISSN 1998-3646 · Wolters Kluwer Medknow Publications · INDIA · Quarterly

Indian Journal of Medical Microbiology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.5; fully open access; APC about USD 2,210; median 106 days to acceptance (108 articles, last 24 months); community-reported acceptance: easy; 189 articles in 2025; indexed in SCIE and Scopus.

Impact factor1.5Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time106 daysMedian, submission to acceptance · 108 articles, last 24 months · PubMed
APCUSD 2,210Fully open access
AcceptanceEasyCommunity average
Articles per year1892025 · OpenAlex count

Scope

Aims, scope and focus

Indian Journal of Medical Microbiology is published by Wolters Kluwer Medknow Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing and Antifungal resistance and susceptibility, together about 25.2% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)

An official journal of the Indian Association of Medical MicrobiologistsIndian Journal of Medical Microbiology (IJMM) provides comprehensive coverage of medical microbiology, as well as infectious diseases. We welcome wide ranging contributions; from basic research at laboratory to clinical trials, including bacteriology, mycobacteriology, virology, mycology and parasitology, infection prevention and control, and infectious diseases.We publish articles under the following subject categories:Antimicrobial susceptibility and antimicrobial stewardship: surveillance of antimicrobial susceptibility in bacteria, viruses, fungi and parasites of importance in humans, animals, and the environment that are frequently interconnected; mechanisms of action, resistance and interactions. The role of antimicrobial stewardship programs in hospitals and its effectiveness.Clinical microbiology: understanding pathogenesis, virulence factors of the diseases caused by bacteria, viruses, mycobacteria, parasites and fungi in humans, clinical presentation, newer methods and tools for diagnosis of disease and therapeutic options; community health with respect to infection burden and prevention, disease epidemiology and climate change.Emerging infectious diseases: understanding the epidemiology of new and emerging infections or old infections having a resurgence in humans including zoonosis; their pathophysiology, clinical presentation, diagnosis and treatment.Medical mycology and mycobacteriology: pathogenesis, diagnosis, drug susceptibility, therapy, clinical immunology, autoimmune diseases, and immune responses to infections, vaccine development, epidemiology, public health and outbreak investigation of diseases in humans.Hospital infection: various hospital associated infections -their analysis, control, prevention and lessons learnt, newer methodologies to track HAI's, hospital outbreaks.Molecular studies: application of phenotypic, genotypic and molecular techniques in the study of virulence, AMR genes, epidemiology, outbreak investigations and public health.Microbiome and microbial ecology in health: the normal microbiome and dysbiosis; structure of microbial ecosystems and communities; microbial ecology, with an emphasis on how microorganisms interact with their environment, their host and each other and their impact on general health and treatment of disease. the normal microbiome and dysbiosis and its association with disease conditions; and microbial ecosystems and communities.Immunology: Clinical immunology, autoimmune diseases, and immune responses to infectionsVaccinology and therapeutics: research in identifying vaccine targets, novel drug discovery and therapeutics.IJMM publishes article types such as original research, review articles, systematic reviews, meta-analysis, clinical trials, correspondence, case reports and a new section - infectious disease grand rounds.High quality scientific content related to infections from dental and veterinary sciences (like zoonotic illnesses) can also be submitted.

From the journal's Aims & Scope

Research area (LetPub): IMMUNOLOGY

Editor-in-chief Sangeeta JoshiPublisher website

Editorial board by country: none in mainland China; most named India 41, United States 8, United Kingdom 7, South Africa 2, Japan 1 (64 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology11.3%
  2. Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology7.1%
  3. Antifungal resistance and susceptibilityMedicine6.8%
  4. Mycobacterium research and diagnosisMedicine5.8%
  5. Tuberculosis Research and EpidemiologyMedicine5.5%
  6. Fungal Infections and StudiesMedicine5.4%
  7. Antimicrobial Resistance in StaphylococcusMedicine5.1%
  8. Antibiotic Use and ResistanceImmunology and Microbiology5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorImmunologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorImmunologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorImmunologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.5LetPub ·
Impact factor (publisher)
1.5Publisher website ·
CiteScore 2026-06
2.2LetPub ·
CiteScore (publisher)
2.2Publisher website ·
SJR 2026-06
0.42LetPub ·
SNIP 2026-06
0.68LetPub ·
h-index
41LetPub ·
h-index
81OpenAlex ·
i10-index
1,272OpenAlex ·
2-year mean citedness
1.2OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
147LetPub ·

Articles by year OpenAlex count · 4,189 in total · the current year is incomplete

YearArticlesOpen accessCitations
202622022024
2025189189185
2024186186506
2023156156624
2022160160825
20216066061,212

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

106 daysMedian, submission to acceptance · P25–P75 73 days – 163 days

Acceptance to online
median 1 days (108 articles)
Submission to online
median 108 days
Sample
108 articles with submission and acceptance dates (425 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·
Submission to first decision
8 daysPublisher website ·
First decision after review
2 daysPublisher website ·
Submission to acceptance
142 daysPublisher website ·
Peer review
Double anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 2,210 / EUR 2,070 / GBP 1,770 / JPY 274,110——
Publisher websiteUSD 2,570——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare5 items from the author guidelines
Abstract
≤ 250 words
Keywords
≥ 3
Manuscript length
≤ 2,500 words
Reference style
Numbered, in order of citation
Cover letter
Required
Publisher website · model-extracted, each line checked against the text
Article types accepted15, with length limits
  1. brief communicationManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …main text ≤ 1,000 words
  2. brief communicationsBrief communications: Word limit of 1000 words. Recommended for brief observations of a study that does not warrant a full length paper.Length not stated
  3. case reportManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …main text ≤ 1,000 words
  4. case reportsCase reports: Word limit of 1000 words. Recommended for description of uncommon infections.Length not stated
  5. editorialnd may not exceed 2500 words; the Guest Editorial may or may not have references and should not exceed maximum of 1000 words and 10 references. Kindly note that…main text ≤ 1,000 words
  6. infectious disease grand roundsInfectious disease Grand rounds: The word limit is 1000 words.Length not stated
  7. letterManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …Length not stated
  8. letters to the editorManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …Length not stated
  9. meta-analysisManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …Length not stated
  10. original researchManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …Length not stated
  11. original research articleManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …Length not stated
  12. original research articles and multicentric studiesOriginal research articles and multicentric studies: We encourage original research articles. These articles must have text shorter than 2500 words, excluding r…Length not stated
  13. reviewManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …Length not stated
  14. systematic reviewManuscripts of high standard in the form of original research, multicentric studies, meta analysis, and systematic review, are accepted. Current reports can be …main text ≤ 3,500 words · abstract ≤ 300 words · references ≤ 50
  15. systematic reviews and meta-analysisSystematic reviews are limited to 3500 words. Word count for Meta-analysis is optional.Length not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
AI use Declaration of generative AI use

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

Source ↗Publisher website ·
Authorship Authorship

By adhering to the authorship requirements stated above, authors meet the International Committee of Medical Journal Editors (ICMJE) criteria [updated version January 2024] on authorship.

Source ↗Publisher website ·
Conflicts of interest Declaration of competing interests

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

Source ↗Publisher website ·
Publication ethics

Ethics in publishing Model summary

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.

Source ↗Publisher website ·
License & copyright License options

Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.

Source ↗Publisher website ·
Open access Open access

We refer you to our open access information page to learn about open access options for this journal.

Source ↗Publisher website ·
Peer review Peer review

Double anonymized peer review Model summary

This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…

Source ↗Publisher website ·
Preprints Preprints

Preprint sharing Model summary

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Wolters Kluwer Medknow Publications
Country or region
INDIA
Language
English
Frequency
Quarterly
ISSN
0255-0857
Electronic ISSN
1998-3646
Society / sponsor
Indian Association of Medical Microbiologists
Official links

FAQ

Frequently asked questions about Indian Journal of Medical Microbiology

What CAS zone is Indian Journal of Medical Microbiology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Indian Journal of Medical Microbiology is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Indian Journal of Medical Microbiology?

The latest impact factor listed by LetPub is 1.5; CiteScore 2.2, h-index 81.

How long does peer review take at Indian Journal of Medical Microbiology?

Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 106 days (interquartile range 73–163 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Indian Journal of Medical Microbiology?

According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Manuscript length: ≤ 2,500 words; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Indian Journal of Medical Microbiology based?

Of the 64 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (41), United States (8) and United Kingdom (7). Counted from the institutions listed on the board page; for reference only.

Which databases index Indian Journal of Medical Microbiology?

According to LetPub and DOAJ records, Indian Journal of Medical Microbiology is indexed in SCIE and Scopus.

Is Indian Journal of Medical Microbiology open access, and what is the APC?

Indian Journal of Medical Microbiology is a fully open-access journal. APC about USD 2,210.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .